TY - JOUR
T1 - Immune cell phenotypes associated with disease severity and long-term neutralizing antibody titers after natural dengue virus infection
AU - Rouers, Angeline
AU - Chng, Melissa Hui Yen
AU - Lee, Bernett
AU - Rajapakse, Menaka P
AU - Kaur, Kaval
AU - Toh, Ying Xiu
AU - Sathiakumar, Durgalakshmi
AU - Loy, Thomas
AU - Thein, Tun-Linn
AU - Lim, Vanessa W X
AU - Singhal, Amit
AU - Yeo, Tsin Wen
AU - Leo, Yee-Sin
AU - Vora, Kalpit A
AU - Casimiro, Danilo
AU - Lim, Bing
AU - Tucker-Kellogg, Lisa
AU - Rivino, Laura
AU - Newell, Evan W
AU - Fink, Katja
N1 - © 2021 The Author(s).
PY - 2021/5/18
Y1 - 2021/5/18
N2 - Prior immunological exposure to dengue virus can be both protective and disease-enhancing during subsequent infections with different dengue virus serotypes. We provide here a systematic, longitudinal analysis of B cell, T cell, and antibody responses in the same patients. Antibody responses as well as T and B cell activation differentiate primary from secondary responses. Hospitalization is associated with lower frequencies of activated, terminally differentiated T cells and higher percentages of effector memory CD4 T cells. Patients with more severe disease tend to have higher percentages of plasmablasts. This does not translate into long-term antibody titers, since neutralizing titers after 6 months correlate with percentages of specific memory B cells, but not with acute plasmablast activation. Overall, our unbiased analysis reveals associations between cellular profiles and disease severity, opening opportunities to study immunopathology in dengue disease and the potential predictive value of these parameters.
AB - Prior immunological exposure to dengue virus can be both protective and disease-enhancing during subsequent infections with different dengue virus serotypes. We provide here a systematic, longitudinal analysis of B cell, T cell, and antibody responses in the same patients. Antibody responses as well as T and B cell activation differentiate primary from secondary responses. Hospitalization is associated with lower frequencies of activated, terminally differentiated T cells and higher percentages of effector memory CD4 T cells. Patients with more severe disease tend to have higher percentages of plasmablasts. This does not translate into long-term antibody titers, since neutralizing titers after 6 months correlate with percentages of specific memory B cells, but not with acute plasmablast activation. Overall, our unbiased analysis reveals associations between cellular profiles and disease severity, opening opportunities to study immunopathology in dengue disease and the potential predictive value of these parameters.
KW - Antibodies, Neutralizing/genetics
KW - Antibodies, Viral/genetics
KW - B-Lymphocytes/immunology
KW - Cross Reactions/immunology
KW - Dengue/immunology
KW - Dengue Virus/genetics
KW - Humans
KW - Phenotype
KW - Plasma Cells/immunology
KW - Serogroup
KW - Time
U2 - 10.1016/j.xcrm.2021.100278
DO - 10.1016/j.xcrm.2021.100278
M3 - Article (Academic Journal)
C2 - 34095880
SN - 2666-3791
VL - 2
JO - Cell reports. Medicine
JF - Cell reports. Medicine
IS - 5
M1 - 100278
ER -